Oncoral (irinotecan oral) - Ascelia
Vectibix (panitumumab) - Amgen, Takeda
Erbitux (cetuximab) - Eli Lilly, EMD Serono
Eylea (aflibercept intravitreal) - Bayer, Regeneron
Cyramza (ramucirumab) - Eli Lilly
Lipoxal (oxaliplatin) - Regulon
Avastin (bevacizumab) - Roche
https://www.onclive.com/view/therasphere-y-90-plus-chemo-prolongs-pfs-hpfs-in-second-line-metastatic-crc
 
Sep 23, 2021
 
Prev Next